This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Becton Dickinson, CR Bard deal cleared with conditions in China

By MLex Staff ( December 28, 2017, 10:29 GMT | Insight) -- China's Ministry of Commerce has conditionally cleared the $24 billion acquisition of C.R. Bard by Becton Dickinson, requiring the divestment of Becton Dickinson’s soft tissue core needle biopsy device business and related research assets. The clearance of the Becton Dickinson-C.R. Bard deal is the seventh case cleared with remedies this year, and marks a new annual record for Mofcom’s conditionally approved transactions.China's Ministry of Commerce has conditionally cleared the $24 billion acquisition of C.R. Bard by Becton Dickinson, requiring the divestment of Becton Dickinson’s soft tissue core needle biopsy device business and related research assets. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login